Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Antibiotic Eyedrops
- Development stage
- Preclinical
- Lead developer
- AFT Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Ophthalmic
01
Overview
AFT Pharmaceuticals is developing a stable, patented aqueous ophthalmic formulation of an antibiotic intended for the treatment of serious eye infections, with a specific focus on antibiotic-resistant bacteria such as Methicillin-Resistant Staphylococcus Aureus (MRSA). The technology, licensed from Latitude Pharmaceuticals, provides a stable solution for an antibiotic that is already approved for other bacterial infections but currently lacks a commercially available ophthalmic product, necessitating the use of pharmacy-compounded drops. The development program was announced in early 2023 and is currently in the IND-enabling phase, with regulatory filings planned for major global markets including the USA, Europe, China, and Japan. The total addressable market for this specialty ophthalmic product is estimated at approximately US$1 billion globally.
- Other names
- Antibiotic Eyedrops
Beyond the preview
Go deeper on Antibiotic Eyedrops.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Antibiotic Eyedrops.